You are here
There is a growing discussion in Australia and internationally about the need to increase focus on delivering value-based health care with a focus on patient outcomes and experience.
IHPA’s Pricing Guidelines and the National Health Reform Agreement include provisions for IHPA to consider the impact on its work of evidence‑based, effective new technologies and innovations in models of health care.
Bundled pricing is where a single price covers a full package of care over a defined period of time, spanning multiple events and settings of care. The intention is for resources and funding to be easier for hospitals to manage, to allow financial flexibility to encourage improved models of care or greater standardisation of evidence-based care, and drive better service delivery in the long run which should lead to better patient outcomes and lower costs.
IHPA has developed a robust set of standard costs for the revised List of standard items associated with conducting clinical trials in Australia.
*The documents on this page may not meet accessibility (WCAG 2.0) requirements. If you need help please contact us using the enquiries.ihpa [at] ihpa.gov.au (IHPA enquiries).